Dual action of chronic ethanol treatment on LPS-induced response in C6 glioma cells  by Loureiro, Samanta Oliveira et al.
Journal of Neuroimmunology 249 (2012) 8–15
Contents lists available at SciVerse ScienceDirect
Journal of Neuroimmunology
j ourna l homepage: www.e lsev ie r .com/ locate / jneuro imDual action of chronic ethanol treatment on LPS-induced response in C6 glioma cells
Samanta Oliveira Loureiro, Luana Heimfarth, Bárbara Ortiz de Lima, Marina C. Leite, Maria Cristina Guerra,
Carlos Alberto Gonçalves, Regina Pessoa-Pureur ⁎
Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, UFRGS, Porto Alegre, RS, Brazil⁎ Corresponding author at: Universidade Federal do R
Ciências Básicas da Saúde, Departamento de Bioquími
anexo, CEP 90035‐003 Porto Alegre, RS, Brazil. Tel.: +5
3308 5535.
E-mail address: rpureur@ufrgs.br (R. Pessoa-Pureur)
0165-5728 © 2012 Elsevier B.V.
doi:10.1016/j.jneuroim.2012.04.004
Open access under the Elsea b s t r a c ta r t i c l e i n f oArticle history:
Received 17 January 2012
Received in revised form 11 April 2012
Accepted 13 April 2012
Keywords:
Ethanol
Lipopolysaccharide
C6 glioma cell
TNFα
Cell signaling
Reactive astrogliosisIn this study we investigated the anti-inﬂammatory effects of chronic ethanol (EtOH) treatment on lipopolysaccha-
ride (LPS)-stimulated C6 glioma cells. The cells were chronically treatedwith 200 mM EtOH; coincubationwith LPS
and EtOH was obtained upon addition of 2 μg/ml LPS to the incubation medium in the last 24 h of EtOH exposure.
We found that EtOH prevented the LPS-induced production of tumor necrosis factor α (TNFα) without decreasing
cell viability. Either LPS treated or EtOH plus LPS treated cells presented upregulated glial ﬁbrillary acidic protein
(GFAP) and downregulated vimentin levels characterizing a program of reactive astrogliosis. Also, EtOH plus LPS
stimulation greatly increased the oxidative stress generation evaluated by DCF-DA measurement, while either
EtOH alone or LPS alone was unable to induce oxidative stress. Western blot analysis indicated that either EtOH,
LPS or EtOH plus LPS treatments are unable to affect Akt/GSK3β signaling pathway. However, LPS alone and EtOH
plus LPS co-treatment inhibited Erk phosphorylation. A dramatic loss of stress ﬁbers was found in EtOH exposed
cells, evaluated by cytochemistry using phalloidin-ﬂuorescein. However, LPS alone was not able to disrupt
actin organization. Furthermore, cells co-incubated with LPS and EtOH presented reversion of the disrupted
stress ﬁbers provoked by EtOH. Supporting this action, RhoA and vinculin immunocontent were upregulated
in response to EtOH plus LPS. Interestingly, EtOH suppresses the inﬂammatory cascade (TNFα production)
in response to LPS. Concomitantly it sustains Erk inhibition, increases oxidative stress generation and induces re-
active astrogliosis in the presence of LPS, conditions associatedwith neurotoxicity. The effects observedwere not
supported by actin reorganization. Altogether, these ﬁndings suggest that Erk signaling inhibition could play a
role in both suppressing TNFα production and inducing oxidative stress generation and astrogliosis, therefore
modulating a dual action of EtOH plus LPS in glial cells.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Neuroinﬂammation is a normal defensemechanismaimed at protect-
ing the CNS against insults such as infection, injury or disease. In most
cases, it constitutes a beneﬁcial process that resolves on its own once
the threat has been eliminated and homeostasis has been restored
(Glass et al., 2010). In some instances, however, the insult can persist
and/or the inﬂammatory process might get out of balance, resulting in
chronic neuroinﬂammation, a deleterious process contributing to the
pathogenesis of several neurological conditions (Allan and Rothwell,
2003; Glass et al., 2010). Together with microglia (the resident immune
cells in the brain), astrocytes are important players in neuroinﬂammatory
processes. This inﬂammatory reaction has recently received attention as
an unexpected potential target for the treatment of diverse diseases
such as Alzheimer's disease, Parkinson disease and amyotrophic lateral
sclerosis (Block et al., 2007; Philips and Robberecht, 2010).io Grande do Sul, Instituto de
ca, Rua Ramiro Barcelos 2600
5 51 3308 5565; fax: +55 51
.
vier OA license.In response to certain pathological conditions of the brain (Polazzi
et al., 1999; Liu et al., 2000; Teeling and Perry, 2009), microglia are
readily activated and undergo a dramatic transformation from their
resting ramiﬁed state into an amoeboid morphology. In their activated
state, they can serve diverse beneﬁcial functions essential to neuron
survival, which include cellular maintenance and innate immunity.
Activated microglia is also involved in regulating brain development
and neurogenesis through the release of trophic and anti-inﬂammatory
factors (Hanisch and Kettenmann, 2007). Recent in vitro studies indicate
the important impact of activated microglia on astrogliosis (Rohl et al.,
2007). This assumption was further supported by the ﬁnding that the
pro-inﬂammatory factors released by microglia play an important role
as triggers and modulators of astrogliosis (Zhang et al., 2010). Therefore,
similar to microglia, astrocytes become activated in response to various
stimuli, from subtle changes in their microenvironment to massive tissue
damage. This process, known as reactive astrogliosis, far from being an
all-or-none event, is a ﬁnely graded and non-homogeneous response
that varies according to the type, severity, time and duration of the insult
(Sofroniew and Vinters, 2010).
Astroglial activation is characterized by a prominent increase in
expression of the intermediate ﬁlament glial ﬁbrillary acidic protein
(GFAP) and the marker aldehyde dehydrogenase 1 family, member
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ciﬁc conditions, contribute to the immune response (Farina et al.,
2007). The functions of reactive astrocytes are not well understood,
and both harmful and beneﬁcial activities are reported. Reactive as-
trocytes can protect neurons and neural function secreting trophic
factors or produce pro-inﬂammatory and cytotoxic cytokines that
are harmful to neurons or oligodendrocytes in the lesioned brain,
which in turn can lead to further damage via, e.g., nitric oxide radicals
and TNFα (Oleszak et al., 1998; Zhang et al., 2010).
Lipopolysaccharide (LPS), which constitutes the lipid portion of
the outer leaﬂet of Gram-negative bacteria, is essential for growth
(Cipolla et al., 2011). However, LPS facilitates the survival of pathogens
by imposing a permeability barrier against antibiotics and antimicrobial
peptides. LPS, also termed as endotoxin, functions as a potent inducer of
innate immunity. Interception of endotoxin in systemic circulation by
immune cells e.g. macrophages is essential to mount surveillance
against invading microbes. LPS binding to the host receptor Toll-like
receptor 4 (TLR4) triggers an inﬂammatory reaction characterized by
the release of large number of inﬂammatory mediators that allow the
host to respond to the invading pathogen (Ianaro et al., 2009). However,
a hyper-activated immune response may lead to the overwhelming
production of tissue damaging cytokines TNFα, interleukin (IL)-1, IL-6
and free radicals that may cause multiple organ failures or septic
shock syndromes (Bhattacharjya, 2010).
Otherwise, numerous studies suggest a role for ethanol (EtOH)
mediating inﬂammatory processes in leukocytes in rat brain (Altura
et al., 2002) or in astroglial cells (Davis and Syapin, 2004; Lee et al.,
2004; Blanco et al., 2005), although cellular and molecular mecha-
nisms by which alcohol causes brain damage are not fully understood.
In this context, excessive consumption of EtOH interferes with intracel-
lular signaling aswell as cytokine responses induced throughmost TLRs
both in vivo and in vitro (Goral and Kovacs, 2005). Also, in vitro exper-
iments using RAW264.7 macrophage-like cell line suggest a novel
mechanism of EtOH action that involves interference with TLR cluster-
ing, and indicate a potential role for actin ﬁlaments in the formation
of receptor patches, subsequent activation of macrophages by LPS, and
production of TNFα (Dai and Pruett, 2006).
The C6 glioma cell (rat glial tumor cell line) has provided the most
appropriate cell line for molecular neurobiologists to study sensitivity of
glial cells to various substances and conditions, because of its similarities
with primary glial cells in culture (Kumar et al., 1984; Vernadakis et al.,
1991). With successive passages (beyond passage 70) C6 glioma cell
differentiates into a primarily astrocytic cell like population (Parker et
al., 1980) and exhibits many properties of astrocytes, including ex-
pression of the astrocyte speciﬁc markers GFAP (Bissell et al.,
1974) and S100B protein (Nardin et al., 2007). Moreover, we have
recently reported the effects of acute treatment with EtOH in C6
glioma cell on actin cytoskeletal organization and we found that this
remodeling could be related with oxidative stress (Loureiro et al.,
2011).
Since little information is available about the roles of EtOHmodulating
neuroinﬂammation under LPS exposure in glial cells, in the present study
we used C6 cells to establish the implications of chronic treatment with
EtOH on some parameters of the inﬂammatory response induced by
LPS. We used coincubation of C6 cells with EtOH plus LPS focusing on
TNFα production, actin reorganization, oxidative stress generation,
reactive astrogliosis and activation of signaling mechanisms such as
AKT/glycogen synthase kinase 3β (AKT/GSK3β) and mitogen activated
protein kinase (MAPK) pathways.
2. Material and methods
2.1. Radiochemicals and compounds
Ethanolwas purchased fromMerck (Darmstadt, Germany) andwas of
analytical grade. Lipopolysaccharide (LPS) from Escherichia coli serotype026:B6, L-2654, benzamidine, leupeptin, antipain, pepstatin, chymostatin,
acrylamide, bis-acrylamide, phalloidin-ﬂuorescein isothiocyanate,
anti-GFAP (clone G‐A-5), monoclonal anti-α-tubulin clone B-5-1-2,
monoclonal anti-β-actin, anti-vinculin, anti-caspase 3, anti-RhoA,
anti-rabbit IgG (whole molecule), F (ab′)2 fragment-Cy3, anti-
mouse IgG (whole molecule)-FITC, peroxidase-conjugated rabbit
anti-mouse IgG, 2′–7′-dichloroﬂuorescein diacetate (DCF-DA) and
material for cell culture were purchased from Sigma (St. Louis, MO,
USA). Polyclonal rabbit anti-glial ﬁbrillary acidic protein was
obtained from Dako Corp. (CA, USA). Anti-GSK-3β, anti-phospho-
GSK-3β, anti-Akt1, anti-phospho-Akt (Thr308), anti-ERK/MAPK,
anti-phosphoERK/MAPK, anti-JNK/MAPK and anti-phosphoJNK/
MAPK were obtained from Cell Signaling Technology. Fetal bovine
serum (FBS), Dulbecco's Modiﬁed Eagle Medium: Nutrient Mixture
F-12 (DMEM/F12), fungizone and penicillin/streptomycin were pur-
chased from Gibco BRL (Carlsbad, CA, USA). All other chemicals were
of analytical grade.
2.2. Maintenance of cell line
The C6 rat glioma cell line was obtained from Rio de Janeiro Cell
Bank (Rio de Janeiro, Brazil). We used C6-glioma cells at passage 90,
expressing GFAP and vimentin. The cells were grown and maintained
in DMEM/F12/10% FBS (pH 7.4) containing 2.5 mg/ml fungizone,
100 mg/ml penicillin/streptomycin and supplemented with glucose
(33 mM), glutamine (2 mM) and sodium bicarbonate (3 mM). Cells
were kept at a temperature of 37 °C, a minimum relative humidity
of 95%, and an atmosphere of 5% CO2 in air.
After cells reached semi-conﬂuence, the culture medium was re-
moved by suction and the cells were incubated for 96 h at 37 °C in an at-
mosphere of 5% CO2/95% air in DMEM/F12 (pH 7.4) containing 2.5% FBS
in the presence or absence (controls) of 200 mM ethanol. Thereafter,
we incubated the treated cells with 2 μg/ml LPS for 24 h. Morphological
studies were performed using cells ﬁxed for immunocytochemistry.
2.3. Lactate dehydrogenase (LDH) assay
The viability was assessed by measuring the release of the cytosolic
enzyme lactate dehydrogenase into themedium. C6 cells were incubated
in the presence or absence of 200 mM ethanol for 96 h and thereafter
added 2 μg/ml LPS for 24 h. LDH measurement was carried out in 250 μl
aliquots using the LDH kit from Doles reagents.
2.4. Evaluation of intracellular oxidative stress generation
Intracellular reactive oxygen species (ROS) productionwas detected
using the nonﬂuorescent cell permeating compound, 2′–7′-dichloro-
ﬂuorescein diacetate (DCF-DA). DCF-DA is hydrolyzed by intracellular
esterases and then oxidized by ROS to a ﬂuorescent compound 2′–7′-
dichloroﬂuorescein (DCF). After treatment with 200 mM ethanol and
2 μg/ml LPS, C6-glioma-cells were treated with DCF-DA (10 μM) for
30 min at 37 °C. Following DCF-DA exposure, the cells were rinsed
and then scraped into PBS with 0.2% Triton X-100. The ﬂuorescence
was measured in a plate reader (Spectra Max GEMINI XPS, Molecular
Devices, USA) with excitation at 485 nm and emission at 520 nm.
2.5. Immunocytochemistry
Immunocytochemistry was performed as described previously
(Gomes et al., 1999). Brieﬂy, cultured cells plated on glass coverslips
were ﬁxed with 4% paraformaldehyde for 30 min and permeabilized
with 0.1% Triton X-100 in phosphate-buffered saline (PBS) for 5 min at
room temperature. After blocking, cells were incubated overnight with
polyclonal anti-GFAP (1:500) and with our monoclonal anti-α-tubulin
(1:500) at room temperature, followed by PBS washes and incubation
with speciﬁc secondary antibody conjugated with Cy3 (1:1000) and
Fig. 1. Effect of chronic ethanol treatment on the ability of LPS in secreting TNFα. Cells
were untreated (controls) or treated for 96 h with 200 mM EtOH; coincubation with
LPS plus EtOH was obtained upon addition of 2 μg/ml LPS to the incubation medium
in the last 24 h of EtOH exposure. The assay was carried out in 100 μl of extracellular
medium, using a rat TNFα ELISA from eBioscience. Four independent experiments
were performed in triplicate. Data were statistically analyzed by one-way ANOVA
followed by Tukey'smultiple variation test. Statistically signiﬁcant differences from controls
are indicated: *Pb0.01.
Fig. 2. Effect of chronic ethanol treatment on LPS-induced cell viability. Cells were
untreated (controls) or treated for 96 h with 200 mM EtOH; coincubation with LPS
plus EtOH was obtained upon addition of 2 μg/ml LPS to the incubation medium in
the last 24 h of EtOH exposure. The viability was assessed by (A) measuring the released
cytosolic enzyme lactate dehydrogenase (LDH) into the medium. LDH measurement was
carried out in 250 μl aliquots using the LDH kit from Doles reagents; and (B) evaluating
the caspase 3 immunocontent in cell homogenate. Immunoblot was carried out with
monoclonal anti-caspase 3 antibody diluted 1:1000. All lanes received equivalent amount
(50 μg) of total protein from cell extract. Representative immunoblot is shown. Four inde-
pendent experiments were performed in triplicate. The blots were developed using an ECL
kit. Representative immunological reactions are shown. Data were statistically analyzed by
one-way ANOVA followed by Tukey's multiple variation test.
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immunostaining-negative controls, reactions were performed by omit-
ting the primary antibody. No reactivitywas observedwhen the primary
antibody was excluded. The actin cytoskeleton was observed using
phalloidin-ﬂuorescein isothiocyanate and the nucleus was stained
with DAPI (0.25 μg/ml). Cells were viewedwith a Nikon invertedmicro-
scope and images were transferred to a computer with a digital camera
(Sound Vision Inc., USA).
2.6. Total protein homogenate
C6 cells were homogenized in 200 μl of a lysis solution containing
2 mM EDTA, 50 mM Tris–HCl, pH 6.8, and 4% SDS. For electrophoresis
analysis, samples were dissolved in 25% (v/v) of a solution containing
40% glycerol, 5% mercaptoethanol, and 50 mM Tris–HCl, pH 6.8, and
boiled for 3 min.
2.7. Polyacrylamide gel electrophoresis (SDS‐PAGE)
The cytoskeletal fraction and the total protein homogenate from C6
cells were prepared as described above. Equal protein concentrations
were loaded onto 10% polyacrylamide gels and analyzed by SDS‐PAGE
according to the discontinuous system of Laemmli (1970).
2.8. Western blot analysis
Total protein homogenate were separated by 10% SDS‐PAGE
(50 μg/lane of total protein) and transferred (Trans-blot SD semidry
transfer cell, BioRad) to nitrocellulose membranes for 1 h at 15 V in
transfer buffer (48 mM Trizma, 39 mM glycine, 20% methanol, and
0.25% SDS). The blot was thenwashed for 10 min in Tris-buffered saline
(TBS) (0.5 MNaCl, 20 mMTrizma, pH 7.5), followed by a 2 h incubation
in blocking solution (TBS plus 5% defatted dry milk). After incubation,
the blot was washed twice for 5 min with blocking solution plus 0.05%
Tween-20 (T-TBS) and then incubated overnight at 4 °C in blocking
solution containing one of the following monoclonal antibodies:
anti-glial ﬁbrillary acidic protein (clone G-A-5) diluted 1:500, α-tubulin
diluted 1:500, actin diluted 1:500, anti-vinculin diluted 1:1000,
anti-RhoA diluted 1:1000, anti-ERK/MAPK diluted 1:1000, anti-
phosphoERK/MAPK diluted 1:1000, anti-JNK/MAPK diluted 1:1000,
and anti-phosphoJNK/MAPK diluted 1:1000. The blot was then
washed twice for 5 min with T-TBS and incubated for 2 h in antibody
solution containing peroxidase-conjugated rabbit anti-mouse IgG diluted
1:2000. The blot was washed twice again for 5 min with T-TBS and
twice for 5 min with TBS. The blot was developed using a chemilumi-
nescence ECL kit (Amersham, Oakville, Ontario).
2.9. S100B measurement
S100B was measured by ELISA, as previously described (Leite et
al., 2008). Brieﬂy, 50 μl of sample plus 50 μl of Tris buffer were incu-
bated for 2 h on a microtiter plate previously coated with monoclonal
anti-S100B. Polyclonal anti-S100 was incubated for 30 min and then
peroxidase-conjugated anti-rabbit antibody was added for a further
30 min. The color reaction with o-phenylenediamine was measured
at 492 nm. The standard S100B curve ranged from 0.002 to 1 ng/ml.
2.10. Tumor necrosis factor alpha (TNFα) measurement
The assay was carried out in 100 μl of extracellular medium, using
a rat TNFα ELISA from eBioscience (San Diego, USA).
2.11. Statistical analysis
Data from the experiments were analyzed statistically by one-way
analysis of variance (ANOVA) followed by the Tukey's test when theF-test was signiﬁcant. Values of Pb0.05 were considered to be signif-
icant. All analyses were carried out in an IBM compatible PC using the
Statistical Package for Social Sciences (SPSS) software.
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We initially evaluated the implication of chronic EtOH treatment
on the ability of LPS in secreting TNFα. For this, C6 glioma cells
were untreated (controls) or treated for 96 h with 200 mM EtOH;
co-incubation with LPS plus EtOH was obtained upon addition of
2 μg/ml LPS to the incubation medium in the last 24 h of EtOH exposure.
As depicted in Fig. 1, EtOH alone failed to induce C6 cells to secrete this
cytokine. This is consistent with Zahr et al. (2010), who described that
binge EtOH treatment for 4 days was insufﬁcient to induce the expres-
sion of several cytokines, including TNFα in blood, liver, or different
brain regions of rats. In addition, our results showed that co-incubation
of C6 cells with EtOH plus LPS abrogated LPS-induced TNFα release in
these cells. This is in line with Dai and Pruett (2006) who found that
acute EtOH exposure suppressed LPS-induced TNFα production in
macrophages.
Cell viability was evaluated under the same conditions and results
showed that neither mitochondrial damage, evaluated by MTT assay
(not shown), nor release of the cytosolic enzyme lactate dehydrogenase
(LDH) into the medium (Fig. 2A) was altered. To further evaluate
whether chronic EtOH exposure, or EtOH plus LPS stimulation was
able to induce apoptosis, wemeasured the immunoreactivity of caspase
3, one of themain executioner caspases implicated in eliciting apoptosis
(D'Amelio et al., 2010). Results showed that either EtOH, LPS or EtOH
plus LPS treatment failed to activate this apoptotic enzyme (Fig. 2B).
Altogether these ﬁndings indicate that the effect of EtOH upon LPS-
mediated release of TNFα was not related to cytotoxicity.
The hallmark of neuroinﬂammation is the activation of glia and the
production of cytokines and inﬂammatory mediators that can trigger
neuronal damage (Minghetti, 2005; Ubogu et al., 2006). In line with
this, either LPS treated or EtOH plus LPS treated cells presented upregu-
lated GFAP (Fig. 3A) and downregulated vimentin levels (Fig. 3B). GFAP
is the major intermediate ﬁlament protein in mature astrocytes andFig. 3. Effect of chronic ethanol treatment on the LPS effect on GFAP and vimentin immunoc
96 h with 200 mM EtOH; coincubation with LPS plus EtOH was obtained upon addition of 2 μ
carried out with anti-GFAP (clone G-A-5) (A) and anti-vimentin (B) antibodies diluted 1:50
shown. All lanes received equivalent amount (50 μg) of total protein from cell extract. (C) S
and then peroxidase-conjugated anti-rabbit antibody was added for a further 30 min. The c
curve ranged from 0.002 to 1 ng/ml. (D) The intracellular ROS levels were measured with D
multiple variation test. Statistically signiﬁcant differences from controls are indicated: *Pb0forms an important part of the cytoskeleton of these cells. Altered ex-
pression of these proteins is considered as part of the spectrum of
changes accompanying reactive astrogliosis (Sofroniew and Vinters,
2010; Zhang et al., 2010). Otherwise C6 cells chronically exposed to
200 mM EtOH were not able to become activated, suggesting that EtOH
on its own does not activate the program of astrogliosis in C6 cells.
We also attempted to investigate S100B secretion in cells chronically
treated with EtOH only, or LPS only, or LPS plus EtOH. S100B is a glial-
derived protein, commonly used as a marker of astroglial activation in
response to different insults (Funchal et al., 2007). Results showed
that either EtOH, LPS or EtOH plus LPS were not able to upregulate
S100B production by C6 cells (Fig. 3C). These ﬁndings could mean a
moderate cell damage, since it has been described that S100B levels gen-
erally correlate with the severity of damage and may have predictive
value for adverse neurological outcomes (Van Eldik and Wainwright,
2003).
Reactive astrocytes also present increased oxidative stress generation,
which potentiallymediate neurotoxic effects (Van Eldik andWainwright,
2003; Farina et al., 2007; Sofroniew and Vinters, 2010). Surprisingly, we
found that regarding this parameter, C6 cells were not responsive to the
effects of either EtOH alone or LPS alone, evaluated by DCF-DA measure-
ment. Conversely, recently we found that C6 cells acutely treatedwith 50
to 200 mM EtOH developed increased ROS levels (Loureiro et al., 2011).
Otherwise, it is interesting to note that EtOH plus LPS stimulation greatly
increased oxidative stress generation, (Fig. 3D), showing that the
concomitant presence of EtOH and LPS is able to provoke an over-
whelming of the oxidative defense mechanisms of the cell. Although at
present we are not able to understand themolecular mechanisms under-
lying these ﬁndings, they highlight the complexity of the cell responses
evoked by EtOH and LPS in different experimental conditions.
We next investigated which signaling events were implicated in
the EtOH-modulated LPS-induced inﬂammatory response. Initially
we were interested in determining if Akt/GSK-3β signaling pathwayontent, S100B levels and ROS production. Cells were untreated (controls) or treated for
g/ml LPS to the incubation medium in the last 24 h of EtOH exposure. Immunoblot was
0. The blots were developed using ECL kit. Representative immunological reactions are
100B was measured by ELISA. Polyclonal antibody anti-S100 was incubated for 30 min
olor reaction with o-phenylenediamine was measured at 492 nm. The standard S100B
CF-DA assay. Data were statistically analyzed by one-way ANOVA followed by Tukey's
.05; **Pb0.01.
Fig. 4. Effect of chronic ethanol treatment on the LPS effect on Akt/GSK-3β activation. Cells were untreated (controls) or treated for 96 h with 200 mM EtOH; coincubation with LPS
plus EtOH was obtained upon addition of 2 μg/ml LPS to the incubation medium in the last 24 h of EtOH exposure. The total and phosphorylated levels of Akt and GSK-3β were
evaluated by Western blot with anti-Akt1 and the ratio phospho‐Akt (Thr308)/total Akt is depicted in (A); the ratio phosphoGSK-3β/totalGSK-3β is depicted in (B). Antibodies
were diluted 1:1000. The blots were developed using ECL kit. Representative immunological reactions are shown. All lanes received equivalent amount (50 μg) of total protein
from cell extract. Data were statistically analyzed by one-way ANOVA followed by Tukey's multiple variation test.
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in C6 cells. Thus, the protein levels of total Akt, phospho-Akt, total
GSK-3β and phospho-GSK-3β were detected by Western blotting. Re-
sults depicted in Fig. 4 A indicate that either EtOH, LPS or EtOH plus
LPS treatments are unable to affect the ratio phospho‐AKT/total AKT.
In concert with these results, modulation of GSK-3β phosphorylation
is not altered in the inﬂammatory response (Fig. 4B). Our ﬁndings are
quite unexpected, since the function of GSK-3β in signaling mecha-
nisms that activate nuclear factor κB (NF-κB), aswell as the resulting ef-
fects on NF-κBmediated gene expression, indicates that GSK-3β acts as
a regulator of inﬂammation (Sanchez et al., 2003; Buss et al., 2004;
Takada et al., 2004), however the potential role and mechanism for
this effect are still controversial.
On the other hand, MAPKs play a critical role in regulating LPS-
induced inﬂammation and transcriptional regulation of inﬂammatory
factors (Surh et al., 2001). To examine whether EtOH affected MAPK
phosphorylation, we analyzed the phosphorylation levels of Erk andFig. 5. Effect of chronic ethanol treatment on the LPS effect on ERK and JNK activation. Cells w
plus EtOH was obtained upon addition of 2 μg/ml LPS to the incubation medium in the last 24
(p56 andp54)were evaluated byWestern blotwith anti-ERK. The ratio phosphoErk (p44 and p
were diluted 1:1000. The blots were developed using ECL kit. Representative immunological re
extract. Data were statistically analyzed by one-way ANOVA followed by Tukey's multiple variJNK in cells treated with EtOH for the entire duration of the experiment,
treated with LPS alone or treated with EtOH plus LPS. Results showed
thatwhile EtOH alonewas unable to affect the ratio phosphoErk/totalErk,
both LPS alone and EtOH plus LPS co-treatment inhibited this ratio
(Fig. 5A). Conversely, despite that EtOH exposure has induced de-
creased phosphoJNK/totalJNK ratio, this kinase seems not to be impli-
cated either in the neuroinﬂammatory action of LPS or in the effects of
EtOH plus LPS co-treatment (Fig. 5B).
Altogether, the insight on some signaling pathways that could be
involved in the cell response to LPS and EtOH led us to hypothesize
a causal link between inhibition of Erk signal transduction and de-
creased TNFα production. Also, reactive astrogliosis and oxidative
stress observed in EtOH plus LPS treated cells could be a consequence
of misregulation of MAPK signaling. Moreover it should be noted that
suppression of TNFα production in EtOH plus LPS stimulated cells is
apparently not sufﬁcient to inhibit signal transduction leading to
cell damage. These ﬁndings could characterize a dual action of EtOH,ere untreated (controls) or treated for 96 h with 200 mM EtOH; coincubation with LPS
h of EtOH exposure. The total and phosphorylated levels of ERK (p44 and p42) and JNK
42)/totalErk is depicted in (A); the ratio phosphoJNK/totalJNK is depicted in (B). Antibodies
actions are shown. All lanes received equivalent amount (50 μg) of total protein from cell
ation test. Statistically signiﬁcant differences from controls are indicated: *Pb0.05.
Fig. 6. Effect of chronic ethanol treatment on the effect of LPS on actin reorganization and immunocontent. Cells were untreated (controls) or treated for 96 h with 200 mM EtOH;
coincubation with LPS plus EtOH was obtained upon addition of 2 μg/ml LPS to the incubation medium in the last 24 h of EtOH exposure. (A) Representative images of control
(untreated) cells; ethanol-treated cells; LPS-treated cell and ethanol plus LPS co-treated cells immunostained with DAPI and phalloidin-ﬂuorescein. Scale bar=50 μm. (B) Western
blot analysis of β-actin immunocontent in cell homogenate. All lanes received equivalent amount (50 μg) of total protein from cell extract. Immunoblot was carried out withmonoclonal
anti-β-actin antibody diluted 1:1000. The blots were developed using ECL kit. Representative immunological reactions are shown. Data represent mean±S.E.M. from four independent
experiments expressed as percent of controls. Statistically signiﬁcant differences from controls were determined by one-way ANOVA followed by Tukey's multiple variation test.
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on the other hand sustaining a signaling pathway probably implicated
in the program of astrogliosis and increased oxidative stress generation.
It is also known that the cell response to LPS is dependent on its
interaction with cell surface TLRs achieving the maximum response
through TLR clustering (Pfeiffer et al., 2001; Dai and Pruett, 2006),
which, in turn, seems to be mediated, at least in part, by rearrangement
of the actin cytoskeleton, which is necessary for the formation of a fully
active receptor complex on the cell surface (Hao and August, 2005; Dai
and Pruett, 2006). Thus, LPS interacts with TLRs before activating down-
stream signaling pathways,which induce the production of TNFα (Tobias
et al., 1989; Schumann et al., 1990; Cheadle et al., 1991). Interestingly, Dai
and Pruett (2006) described that, in macrophages, acute EtOH treatmentinterferes with intracellular signaling elicited by LPS by suppressing LPS-
induced actin reorganization, therefore preventing TLR clustering and
consequent TNFα release (Pruett et al., 2004; Goral and Kovacs, 2005).
Therefore, to access the effects of chronic EtOH or EtOH plus LPS
treatment on actin cytoskeleton of C6 cells, we carried out cytochemical
analysis using phalloidin-ﬂuorescein to decorate actin. Results
depicted in Fig. 6A show that in untreated cells actin was distributed
into numerous well-organized actin stress ﬁbers into the cytoplasm.
After EtOH exposure for 96 h, we observed a dramatic loss of stress
ﬁbers and more diffuse organization of actin ﬁlaments. In line with
the implications of actin cytoskeleton in the response of C6 cells to
EtOH exposure, chronic EtOH caused alterations in actin organization in
rat astrocytes, consisting of the dissolution of stress ﬁbers (Martinez et
14 S.O. Loureiro et al. / Journal of Neuroimmunology 249 (2012) 8–15al., 2007). In addition, Tomas et al. (2003) registered the appearance
of circular ﬁlaments beneath the plasma membrane in EtOH-treated
astrocytes. Accordingly, we previously described that in C6 cells
acutely exposed to 200 mM EtOH elevated ROS levels were related
with the EtOH-evoked disruption of actin organization (Loureiro et
al., 2011). However, in the present results we show that the action
of chronic EtOH exposure on actin reorganization was not mediated
by ROS and further experiments will be necessary to elucidate the
mechanisms underlying this effect.
Interestingly, in the presence of LPS alone the phalloidin-ﬂuorescein
labeling throughout the cytoplasm remained similar to that of untreated
cells. Furthermore,when cellswere co-incubatedwith LPS plus EtOHwe
observed a LPS-induced reversion of the disrupted stress ﬁbers pro-
voked by EtOH. It is interesting to note that actin immunocontent,
evaluated by Western blot analysis, was not altered upon the different
experimental conditions (Fig. 6B). Supporting restoration of actin ar-
chitecture, RhoA and vinculin immunocontent were upregulated in
extracts of cells treated with EtOH plus LPS, as evaluated by Western
blot analysis using speciﬁc monoclonal antibodies against these two
proteins (results not shown). RhoA is a mononeric GTPase activated
by lysophosphatidic acid (LPA), which is a normal constituent of
serum and a potent activator of RhoA known to stimulate stress
ﬁber formation (Ridley and Hall, 1992) whereas vinculin allows efﬁ-
cient interaction with the cell surface and promotes actin stress ﬁber
assembly (Le Clainche and Carlier, 2008). Also, decreased content of
RhoA suggests inhibition of this monomeric GTPase signaling path-
way (Loureiro et al., 2011). In this context, Martinez et al. (2007)
have described alterations of the actin cytoskeleton organization
and dynamics, as well as downregulation of members of Rho GTPase
family in cultured astrocytes chronically exposed to ethanol atmoderate
(30 mmol/l) and high (100 mmol/l) concentrations. To further in-
vestigate the participation of the other cytoskeletal constituents
on the action of EtOH on LPS cell response, we also investigated
the organization of the microtubules and GFAP networks in C6-glioma
cells. Immunocytochemical analysis using anti-α-tubulin or anti-GFAP
antibodies showed that in cells chronically exposed to EtOH, in cells
stimulated with LPS alone, or co-incubated with LPS plus EtOH, micro-
tubule and GFAP arrays were not altered as compared to untreated
cells (results not shown).
Therefore, our present ﬁndings lead us to postulate that EtOH and
LPS co-treatment is able to abrogate the LPS-induced TNFα production
while restoring the stress ﬁbers through activation of RhoA-mediated
mechanisms. Thus it is tempting to speculate that the mechanisms in-
volved in the TNFαproduction following LPS stimulation are not directly
related with the reorganization of the cytoskeleton in C6 cell, as it was
found in macrophages (Dai and Pruett, 2006).
Otherwise, it is important to emphasize that EtOH suppresses the
inﬂammatory cascade leading to decreased TNFα production in re-
sponse to LPS, therefore downregulating the inﬂammatory response.
Concomitantly the alcohol sustains ROS production and reactive
astrogliosis aswell as Erk inhibition induced by LPS, conditions associated
with neurotoxicity. Altogether, these ﬁndings could mean that EtOH
elicits a dual action in glial cell and probably Erk signaling takes part of
the signaling pathways leading to cellular injury.
Considering that astrocytes are polyvalent cells implicated in almost
all processes that occur in the CNS, and that chronic alcohol consump-
tion is associated with neuroinﬂammation and neurodegeneration,
the vulnerability of glial cells under EtOH inﬂuence on neuroinﬂamma-
tory processes may have important implications for understanding the
neurotoxicity linked to several disorders of the CNS.
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